Literature DB >> 24382086

Clinical decisions. Management of type 2 diabetes--polling results.

Joann M Schulte, Carla S Rothaus, Jonathan N Adler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24382086     DOI： 10.1056/NEJMclde1314028

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  3 in total

1.  Acute metformin preconditioning confers neuroprotection against focal cerebral ischaemia by pre-activation of AMPK-dependent autophagy.

Authors:  Teng Jiang; Jin-Tai Yu; Xi-Chen Zhu; Hui-Fu Wang; Meng-Shan Tan; Lei Cao; Qiao-Quan Zhang; Li Gao; Jian-Quan Shi; Ying-Dong Zhang; Lan Tan
Journal:  Br J Pharmacol       Date:  2014-07       Impact factor: 8.739

2.  Efficacy and safety of adding evogliptin versus sitagliptin for metformin-treated patients with type 2 diabetes: A 24-week randomized, controlled trial with open label extension.

Authors:  Sang-Mo Hong; Cheol-Young Park; Dong-Min Hwang; Kyung Ah Han; Chang Beom Lee; Choon Hee Chung; Kun-Ho Yoon; Ji-Oh Mok; Kyong Soo Park; Sung-Woo Park
Journal:  Diabetes Obes Metab       Date:  2017-02-22       Impact factor: 6.577

3.  Metformin Inhibits Propofol-Induced Apoptosis of Mouse Hippocampal Neurons HT-22 Through Downregulating Cav-1.

Authors:  Jianyun Ge; Yulin Huang; Yi Zhang; Lin Liu; Tianyu Gu; Xu Liu; Lei Yao; Mengmeng Cai; Jiafeng Sun; Jie Song
Journal:  Drug Des Devel Ther       Date:  2020-04-21       Impact factor: 4.162
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.